Compare Cassava Sciences Inc (FLNA) vs Rigetti Computing Inc (RGTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Rigetti Computing Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Rigetti Computing Inc trades at $14.21 (market cap $5.07B). The key difference: Rigetti Computing Inc is far larger — about 95.4× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.
| FLNA | RGTI | |
|---|---|---|
Market Cap | $53.14M | $5.07B |
Sector | Health | Technology |
52-Week High | $4.64 | $56.34 |
52-Week Low | $1.09 | $12.90 |
Enterprise Value | -$33.43M | $4.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Rigetti Computing (RGTI) trades at $14.72, down 8.63% with bearish technical signals. The company shows negative profitability with -2,253.59% net margin and -$216.21M net loss in 2025, though quarterly EPS has beaten expectations. Analyst sentiment remains strong with 85.71% buy ratings and $32.67 consensus target. Recent news highlights quantum computing sector volatility and Rigetti's infrastructure advancements amid ongoing cash burn.
The stock offers high-risk growth potential in quantum computing with significant analyst upside but faces substantial execution risks. Key challenges include persistent losses, cash burn of $22.82M in 2025, and intense sector competition. Investment suitability depends on risk tolerance for pre-revenue technology ventures with long commercialization timelines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →
